These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35267980)

  • 21. Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19.
    de Barcelos Ubaldo Martins L; Jabour LGPP; Vieira CC; Nery LCC; Dias RF; Simões E Silva AC
    Curr Med Chem; 2021; 28(22):4499-4530. PubMed ID: 32881654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.
    Alnefaie A; Albogami S
    Saudi Pharm J; 2020 Nov; 28(11):1333-1352. PubMed ID: 32905015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
    Yasmin H; Saha S; Butt MT; Modi RK; George AJT; Kishore U
    Adv Exp Med Biol; 2021; 1313():99-134. PubMed ID: 34661893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of dysregulated immune responses in COVID-19 pathogenesis.
    Tahaghoghi-Hajghorbani S; Zafari P; Masoumi E; Rajabinejad M; Jafari-Shakib R; Hasani B; Rafiei A
    Virus Res; 2020 Dec; 290():198197. PubMed ID: 33069815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.
    Shenoy S
    Inflamm Res; 2022 Jan; 71(1):13-26. PubMed ID: 34738147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
    Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
    Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micronutrients as immunomodulatory tools for COVID-19 management.
    Gasmi A; Tippairote T; Mujawdiya PK; Peana M; Menzel A; Dadar M; Gasmi Benahmed A; Bjørklund G
    Clin Immunol; 2020 Nov; 220():108545. PubMed ID: 32710937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
    Singh KK; Chaubey G; Chen JY; Suravajhala P
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19).
    Tizaoui K; Zidi I; Lee KH; Ghayda RA; Hong SH; Li H; Smith L; Koyanagi A; Jacob L; Kronbichler A; Shin JI
    Int J Biol Sci; 2020; 16(15):2906-2923. PubMed ID: 33061805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
    Mok DZL; Chan CYY; Ooi EE; Chan KR
    FEBS J; 2021 Sep; 288(17):5055-5070. PubMed ID: 33124149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Nutrition During the COVID-19 Pandemic: What We Know.
    Vitale E; Magrone M; Galatola V; Magrone T
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1982-1992. PubMed ID: 33459251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
    Reche PA
    Front Immunol; 2020; 11():586984. PubMed ID: 33178220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.